# Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19)

> **NCT04565392** · PHASE4 · WITHDRAWN · sponsor: **drpykessupplements.com**

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Famotidine 20 milligram tablet

## Key facts

- **NCT ID:** NCT04565392
- **Lead sponsor:** drpykessupplements.com
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-05-01
- **Primary completion:** 2021-11-01
- **Final completion:** 2022-01-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2021-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565392, "Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04565392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*